Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact

PD-L1 Protein Is Predictive of Mesothelioma Survival

Published on October 16, 2020

Oncologists have a list of characteristics that suggest that a mesothelioma patient will be more or less likely to have a longer or shorter survival time. Being female, being younger, or in better health without co-morbidities at the time of diagnosis, are all indicators of a better prognosis. Now researchers from the Linyi People’s Hospital in China have determined that over expression of the PD-L1 protein can be used to predict whether a patient will succumb quickly to the disease or be able to live for a sustained period of time.

Retrospective Mesothelioma Study Shows PD-L1 Impact on Survival

While malignant mesothelioma is always considered fatal, some patients die months after their diagnosis while others enjoy five or more years with a good quality of life. Most of these longer-lived patients have either been identified as having the epithelioid subtype of the disease or female, younger, or otherwise in good health. Researchers have been trying to identify biomarkers that could also guide treatment plans. 

The two Chinese scientists were aware that others in the mesothelioma research field had suspected a connection between PD-L1 expression and mesothelioma prognosis, so they conducted a search of previous studies to see whether they could extract confirming data.

Retrospective Study Confirms High PD-L1 Level As Indicator of Poor Mesothelioma Survival

PD-L1 is present in all of us in different levels. It plays an important role in protecting pregnancies and in fending off some autoimmune diseases, as it suppresses and kills off the part of the immune system that recognizes and responds to foreign tissue. Where these are positive actions, the protein also has the unfortunate effect of working against the immune system’s defense against cancer cells.

The two researchers identified almost a dozen studies that measured PD-L1 levels in mesothelioma patient tissue samples and compared survival times of those patients. Their study included data from over 1,600 patients and confirmed that PD-L1 expression was elevated in patients who had shorter survival times. This important information will be very helpful to physicians in the future, and may guide their discussions with their patients as well as their formulation of treatment plans.

If you or someone you love has been diagnosed with malignant mesothelioma, you need the most up-to-date information on the treatment of the disease. For more resources, contact the Patient Advocates at Mesothelioma.net at 1-800-692-8608.

FREE Mesothelioma Packet

Written by Terri Oppenheimer

Terri Heimann Oppenheimer
Terri Heimann Oppenheimer is the head writer of our Mesothelioma.net news blog. She graduated from the College of William and Mary with a degree in English. Terri believes that knowledge is power and she is committed to sharing news about the impact of mesothelioma, the latest research and medical breakthroughs, and victims’ stories.

Learn more about and contact Terri
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net